Scotia Capital’s ONCOLYTICS BIOTECH INC ONCY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q4
Sell
-10,615
Closed -$5K 856
2015
Q3
$5K Hold
10,615
﹤0.01% 771
2015
Q2
$5K Sell
10,615
-34,080
-76% -$23.2K ﹤0.01% 744
2015
Q1
$33K Buy
44,695
+29,830
+201% +$19.1K ﹤0.01% 595
2014
Q4
$8K Buy
+14,865
New +$8.99K ﹤0.01% 568

Other funds holding ONCY

Scotia Capital's ONCY Position: Q4 2015 in Review

Scotia Capital sold out of ONCOLYTICS BIOTECH INC (ONCY) in Q4 2015, closing a stake of 10,615 shares — an estimated $5K sold.

Scotia Capital first reported a position in ONCY in Q4 2014 and held it in 4 quarters. The position peaked at $33K in Q1 2015. 7 funds tracked by Wall St. Rank hold ONCY as of Q4 2015.

  • Scotia Capital reported no remaining ONCOLYTICS BIOTECH INC position as of Q4 2015 after selling out during the quarter.
  • Scotia Capital sold 10,615 ONCOLYTICS BIOTECH INC shares in Q4 2015, an estimated $5K.
  • Scotia Capital first reported a position in ONCOLYTICS BIOTECH INC in Q4 2014 and held it in 4 quarters.
  • Scotia Capital's ONCOLYTICS BIOTECH INC position peaked at $33K in Q1 2015.
  • 7 funds tracked by Wall St. Rank held ONCOLYTICS BIOTECH INC as of Q4 2015.

Based on Scotia Capital's 13F filing for Q4 2015, filed 11 Feb 2016.